Zarifa Orta

Dr. Zarifa Orta


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
MKMert Ahmet Kuskucu
Mert Ahmet Kuskucu
YTYeşim Tuyji Tok
Yeşim Tuyji Tok
ONOkan Kadir Nohut
Okan Kadir Nohut
ZOZarifa Orta
Zarifa Orta
EYEbru Yücebag
Ebru Yücebag
KMKenan Midilli
Kenan Midilli
Keeping track of SARS-CoV-2 variants of concern (VOC) is crucial to inform public health efforts and limiting the ongoing pandemic. Here, we describe the first detection of SARS-CoV-2 P.1 lineage in Turkey. The fact that new variants can be detected in every geography of the world indicates the need for more whole genome sequencing in order to better understand virus dynamics and take earlier action. Keywords: SARS-CoV-2, P.1 lineage, Variant of Concern (VOC), mutations

25 September 2025 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
ZOZarifa Orta
Zarifa Orta
ACArif Atahan Cagatay
Arif Atahan Cagatay
Pityriasis rubra pilaris (PRP) is a papulosquamous disease of unknown etiology that progresses from keratoderma to erythroderma, particularly affecting the palms and soles. It is classified into five subtypes. The form associated with human immunodeficiency virus (HIV) infection is defined as type 6. Pityriasis rubra pilaris

12 June 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
ZOZarifa Orta
Zarifa Orta
CKCaglar Kavak
Caglar Kavak
BIBurcu Isik-Goren
Burcu Isik-Goren
TDTugba Demircioglu
Tugba Demircioglu
MKMuhammed Enes Kardan
Muhammed Enes Kardan
IUirem kirac utku
irem kirac utku
Brucellosis is a zoonotic infection with a wide clinical spectrum, ranging from nonspecific symptoms to severe focal involvement. Focal involvement significantly affects disease prognosis, yet early prediction remains challenging. Easily accessible inflammatory markers may provide a practical solution for early risk stratification. The aim of this study was to evaluate clinical and laboratory factors associated with focal involvement in brucellosis and to investigate the predictive value of inflammatory markers, particularly C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR). This retrospective observational study included adult patients diagnosed with brucellosis between January 2021 and December 2025 at a tertiary care center. Focal involvement was defined based on clinical findings confirmed by imaging modalities. Demographic, clinical, epidemiological, and laboratory data were collected. Patients were divided into focal and non-focal groups. Multivariate logistic regression analysis was performed to identify independent predictors. Receiver operating characteristic (ROC) analysis was used to assess predictive performance and determine optimal cut-off values. A total of 173 patients were included, of whom 54 (31.2%) had focal involvement. Osteoarticular involvement, particularly spondylodiscitis, was the most common presentation. Patients with focal involvement were older and had significantly higher CRP, erythrocyte sedimentation rate, NLR, and MLR levels (p < 0.05). In multivariate analysis, CRP (OR 1.015, 95% CI 1.004-1.028, p = 0.003) and NLR (OR 1.341, 95% CI 1.012-1.778, p = 0.041) were identified as independent predictors. The combined CRP-NLR model demonstrated moderate discriminative ability (AUC: 0.714). Optimal cut-off values were 42 mg/L for CRP and 1.62 for NLR. Focal involvement in brucellosis is more closely associated with systemic inflammatory response than epidemiological factors. CRP and NLR may serve as cost-effective and clinically useful markers for early identification of patients at risk. Their combined use may support early decision-making and guide the need for further diagnostic evaluation. Larger prospective studies are needed to validate these findings. Not applicable.

23 July 2025 in International Journal of STD & AIDS
Verified
Journal Article
Closed access
ZOZarifa Orta
Zarifa Orta
ABAysun Benli
Aysun Benli
AÇArif Atahan Çağatay
Arif Atahan Çağatay
SBSeniha Başaran
Seniha Başaran
SESimge Erdem
Simge Erdem
SBSevgi Beşişik
Sevgi Beşişik
Background: Kaposi sarcoma in people living with HIV and AIDS usually involves slowly progressive skin lesions. Cases of Kaposi sarcoma complicated by hemophagocytic lymphohistiocytosis are rare. In this report, we present the first series of hemophagocytic lymphohistiocytosis cases from Türkiye associated with AIDS and Kaposi sarcoma. Methods: Cases of hemophagocytic lymphohistiocytosis in people living with HIV and AIDS and Kaposi sarcoma who met the HLH-2004 diagnostic criteria recommended by the “Histiocyte Society” were included in the study. The patient’s demographic, clinical, and laboratory characteristics were recorded retrospectively. Results: Four patients presented with fever, cytopenia, peripheral lymphadenomegaly, splenomegaly, and hepatomegaly. Fever persisted throughout their hospitalization. At the time of HLH diagnosis, Kaposi sarcoma was detected in the lymph node biopsies of one patient and in the skin biopsies of three patients. Hemophagocytosis was observed in bone marrow aspirations from all patients. Three patients received dexamethasone and etoposide for hemophagocytic lymphohistiocytosis treatment, while one received dexamethasone alone. All four patients died. Conclusions: Cases of hemophagocytic lymphohistiocytosis associated with Kaposi sarcoma and AIDS are rare in the literature. In conclusion, high fever may appear in the early stages of Kaposi sarcoma in people living with HIV and AIDS. Since hemophagocytic lymphohistiocytosis has a high mortality rate, early diagnosis and prompt initiation of appropriate treatment are crucial.

27 February 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
MKMurat Hakan Kır
Murat Hakan Kır
ABAysun BENLİ
Aysun BENLİ
ZOZarifa Orta
Zarifa Orta
SBSeniha Başaran
Seniha Başaran
MOMerih Oray
Merih Oray
HÖHalit Özsüt
Halit Özsüt
Syphilis is a re-emerging sexually transmitted infection with rising incidence worldwide, often associated with HIV infection. Ocular syphilis represents a severe manifestation that can occur at any disease stage and may result in permanent vision loss if not promptly diagnosed and treated. We conducted a retrospective comparative cohort study of 22 patients with ocular syphilis managed at Istanbul University, Istanbul Faculty of Medicine, between 2019 and 2025. Twelve patients (54.5%) were people living with HIV (PLWH). The majority were male (81.8%), with a mean age of 45.2 years. Visual loss was observed in more than half of the patients and occurred significantly more frequently in PLWH than in HIV-negative individuals (100% vs. 70%; p = 0.046). Vitritis was also significantly more frequent among PLWH (91.7% vs. 40%; p = 0.02), indicating more severe intraocular inflammation. All six cases of neurosyphilis were confined to PLWH (50% vs. 0%; p = 0.004). The most common ocular manifestations were uveitis (90.9%), predominantly panuveitis and posterior uveitis. All patients received intravenous penicillin G or ceftriaxone, and systemic corticosteroids were administered in half of the cases. Clinical improvement was observed in all patients. Our findings highlight that ocular syphilis in PLWH is associated with more severe inflammation and higher neurosyphilis risk, underscoring the importance of routine cerebrospinal fluid examination and neurosyphilis-based treatment strategies in this group.

22 January 2026 in Biomarkers in Medicine
Verified
Journal Article
Closed access
HOHuseyin Orta
Huseyin Orta
CACihan Aydın
Cihan Aydın
ADAykut Demirkiran
Aykut Demirkiran
ZOZarifa Orta
Zarifa Orta
This study aimed to investigate the predictive value of the C-reactive protein-albumin-lymphocyte (CALLY) index for mortality in patients diagnosed with Infective Endocarditis (IE). We retrospectively analyzed 100 patients diagnosed with IE based on Duke criteria between 2016 and 2024. The CALLY index was calculated at admission using the formula: [(albumin × lymphocyte count)/CRP]. Demographic, clinical, laboratory, and echocardiographic data were collected. Mortality occurred in 55% of patients. The deceased group had significantly lower CALLY index values compared to survivors (median: 1.7 vs. 6.9, p < 0.001). Multivariate analysis identified male sex (OR 3.791, p = 0.043), diabetes mellitus (OR 4.126, p = 0.022), and a lower CALLY index (OR 0.824, p = 0.005) as independent predictors of mortality, with lower CALLY values being associated with a higher risk of death. The CALLY index demonstrated moderate discriminative power (AUC = 0.792) with a cutoff value of 3.3, which yielded 68.9% sensitivity and 69.1% specificity. The CALLY index, an accessible and cost-effective biomarker, is independently associated with mortality and may serve as a hypothesis-generating tool for risk stratification in IE patients. Its incorporation into routine clinical assessment may enhance early risk stratification and guide management strategies.